302 related articles for article (PubMed ID: 34659346)
1. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.
Li D; Lin X; Chen B; Ma Z; Zeng Y; Wang H
Front Genet; 2021; 12():723802. PubMed ID: 34659346
[No Abstract] [Full Text] [Related]
2. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.
Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H
Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154
[TBL] [Abstract][Full Text] [Related]
3. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Zhong W; Zhang F; Huang C; Lin Y; Huang J
Front Oncol; 2020; 10():591254. PubMed ID: 33324563
[TBL] [Abstract][Full Text] [Related]
4. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
Li C; Zheng L; Xu G; Yuan Q; Di Z; Yang Y; Dong X; Hou J; Wu G
Front Endocrinol (Lausanne); 2023; 14():1154741. PubMed ID: 37538794
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
6. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
7. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
[No Abstract] [Full Text] [Related]
9. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
10. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
Huang S; Li D; Zhuang L; Zhang J; Wu J
Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
12. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
13. Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615.
Shan Y; Xia T; Xie W; Wan W; Wu N; Yuan Z; Hu Q; Chen Z; Li C; Wu L; Wu W; Cai T; Xiang Y; Bai L; Li Y
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17781-17793. PubMed ID: 37934255
[TBL] [Abstract][Full Text] [Related]
14. Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma.
Xiao L; Huang Y; Li Q; Wang S; Ma L; Fan Z; Tang Z; Yuan X; Liu B
Front Mol Biosci; 2022; 9():976878. PubMed ID: 36060239
[No Abstract] [Full Text] [Related]
15. Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Zhang Q; Wu X; Sun Y; Yang L; Wang Z; Yang Y; Zhao X; Zhang X
Am J Transl Res; 2022; 14(10):7308-7323. PubMed ID: 36398231
[TBL] [Abstract][Full Text] [Related]
16. Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma.
Tao H; Zhang Y; Yuan T; Li J; Liu J; Xiong Y; Zhu J; Huang Z; Wang P; Liang H; Zhang E
Aging (Albany NY); 2022 Feb; 14(3):1473-1491. PubMed ID: 35148283
[TBL] [Abstract][Full Text] [Related]
17. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
[TBL] [Abstract][Full Text] [Related]
18. Identification of Epithelial-Mesenchymal Transition-Related lncRNAs that Associated With the Prognosis and Immune Microenvironment in Colorectal Cancer.
Liu C; Hu C; Li J; Jiang L; Zhao C
Front Mol Biosci; 2021; 8():633951. PubMed ID: 33898515
[No Abstract] [Full Text] [Related]
19. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
Front Genet; 2021; 12():709329. PubMed ID: 34777458
[No Abstract] [Full Text] [Related]
[Next] [New Search]